Morgan Stanley’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
1,975,027
+778,940
+65% +$993K ﹤0.01% 4595
2026
Q1
$1.36M Buy
1,196,087
+278,734
+30% +$343K ﹤0.01% 4984
2025
Q4
$1.16M Buy
917,353
+79,752
+10% +$111K ﹤0.01% 5107
2025
Q3
$1.3M Sell
837,601
-1,221,453
-59% -$1.68M ﹤0.01% 5037
2025
Q2
$2.72M Sell
2,059,054
-2,049,434
-50% -$2.8M ﹤0.01% 4511
2025
Q1
$6.82M Buy
4,108,488
+940,546
+30% +$1.55M ﹤0.01% 3656
2024
Q4
$4.66M Buy
3,167,942
+1,838,554
+138% +$2.81M ﹤0.01% 4060
2024
Q3
$1.98M Buy
1,329,388
+532,711
+67% +$791K ﹤0.01% 4660
2024
Q2
$996K Sell
796,677
-504,951
-39% -$655K ﹤0.01% 4960
2024
Q1
$1.56M Sell
1,301,628
-568,715
-30% -$569K ﹤0.01% 4716
2023
Q4
$2.82M Buy
1,870,343
+431,243
+30% +$623K ﹤0.01% 4301
2023
Q3
$2.3M Buy
1,439,100
+24,189
+2% +$44.1K ﹤0.01% 4295
2023
Q2
$3.07M Buy
1,414,911
+29,920
+2% +$46.8K ﹤0.01% 4130
2023
Q1
$2.02M Buy
1,384,991
+288,027
+26% +$371K ﹤0.01% 4457
2022
Q4
$1.37M Sell
1,096,964
-250,945
-19% -$395K ﹤0.01% 4687
2022
Q3
$2.55M Sell
1,347,909
-14,635
-1% -$34.6K ﹤0.01% 4263
2022
Q2
$3.45M Sell
1,362,544
-1,259,030
-48% -$3.67M ﹤0.01% 4093
2022
Q1
$9.02M Buy
2,621,574
+1,760,173
+204% +$6.22M ﹤0.01% 3021
2021
Q4
$4.14M Sell
861,401
-262,464
-23% -$1.06M ﹤0.01% 3911
2021
Q3
$4.1M Sell
1,123,865
-259,666
-19% -$967K ﹤0.01% 3940
2021
Q2
$5.6M Buy
1,383,531
+124,720
+10% +$489K ﹤0.01% 3661
2021
Q1
$5.4M Sell
1,258,811
-154,098
-11% -$736K ﹤0.01% 3324
2020
Q4
$5.58M Sell
1,412,909
-405,529
-22% -$1.69M ﹤0.01% 3145
2020
Q3
$6.71M Buy
1,818,438
+1,098,178
+152% +$4.64M ﹤0.01% 2424
2020
Q2
$2.46M Sell
720,260
-1,387,131
-66% -$3.11M ﹤0.01% 3397
2020
Q1
$2.82M Sell
2,107,391
-3,182,573
-60% -$4.99M ﹤0.01% 3036
2019
Q4
$7.78M Buy
5,289,964
+3,747,066
+243% +$6.27M ﹤0.01% 2693
2019
Q3
$3.22M Sell
1,542,898
-159,361
-9% -$326K ﹤0.01% 3345
2019
Q2
$4.15M Sell
1,702,259
-1,670,080
-50% -$3.64M ﹤0.01% 3108
2019
Q1
$8.8M Buy
3,372,339
+1,992,341
+144% +$6.03M ﹤0.01% 2158
2018
Q4
$4.15M Sell
1,379,998
-133,846
-9% -$454K ﹤0.01% 3098
2018
Q3
$5.24M Sell
1,513,844
-928,443
-38% -$4.93M ﹤0.01% 3144
2018
Q2
$11.5M Buy
2,442,287
+220,051
+10% +$835K ﹤0.01% 2218
2018
Q1
$7.04M Buy
2,222,236
+315,796
+17% +$1.27M ﹤0.01% 2676
2017
Q4
$9.34M Sell
1,906,440
-249,145
-12% -$1.45M ﹤0.01% 2467
2017
Q3
$14.8M Sell
2,155,585
-532,621
-20% -$3.36M ﹤0.01% 1884
2017
Q2
$17.7M Sell
2,688,206
-93,105
-3% -$653K 0.01% 1643
2017
Q1
$22.3M Sell
2,781,311
-1,898,756
-41% -$16M 0.01% 1466
2016
Q4
$43.5M Sell
4,680,067
-325,962
-7% -$3.37M 0.01% 973
2016
Q3
$53M Buy
5,006,029
+88,214
+2% +$878K 0.02% 820
2016
Q2
$45.9M Sell
4,917,815
-449,053
-8% -$4.56M 0.02% 841
2016
Q1
$55.8M Buy
5,366,868
+2,477,606
+86% +$22.6M 0.02% 703
2015
Q4
$29M Buy
2,889,262
+36,717
+1% +$368K 0.01% 1138
2015
Q3
$24M Buy
2,852,545
+967,596
+51% +$12.8M 0.01% 1240
2015
Q2
$30.3M Buy
1,884,949
+724,529
+62% +$11.3M 0.01% 1178
2015
Q1
$16.4M Sell
1,160,420
-1,184,343
-51% -$15.4M 0.01% 1613
2014
Q4
$23.4M Sell
2,344,763
-153,548
-6% -$1.31M 0.01% 1353
2014
Q3
$21.3M Sell
2,498,311
-628,892
-20% -$5.53M 0.01% 1397
2014
Q2
$27.6M Sell
3,127,203
-190,759
-6% -$1.67M 0.01% 1174
2014
Q1
$30.9M Buy
3,317,962
+1,071,750
+48% +$9.39M 0.01% 1048
2013
Q4
$19M Buy
2,246,212
+305,920
+16% +$3.09M 0.01% 1391
2013
Q3
$17.1M Buy
1,940,292
+717,424
+59% +$5.75M 0.01% 1341
2013
Q2
$8.68M Buy
+1,222,868
New +$8.45M ﹤0.01% 1811

Other funds holding OPK

Morgan Stanley's OPK Position: Q2 2026 in Review

Morgan Stanley increased its Opko Health (OPK) stake by 65% in Q2 2026, buying an estimated $993K and bringing the position to 1,975,027 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #4595.

Morgan Stanley first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.8M in Q1 2016. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Morgan Stanley held 1,975,027 shares of Opko Health worth $2.96M as of Q2 2026.
  • Morgan Stanley bought 778,940 Opko Health shares in Q2 2026, an estimated $993K.
  • Opko Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4595 holding.
  • Morgan Stanley first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Opko Health position peaked at $55.8M in Q1 2016.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.